BenzingaSeptember 9, 2026 at 10:03 AM NYLast Month
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $415
UBS analyst Doug Schenkel maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $340 to $415.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
